Group | Lymphocyte count | CD4+ | CD8+ | CD28 + CD4+ | Activated CD4+ | CD28 + CD8+ | Activated CD8+ | CD4/CD8 ratio | CD3+ | PDCs | MDCs |
---|---|---|---|---|---|---|---|---|---|---|---|
Experimental group | 1.70 × 109(1.33–2.04 × 109) | 35.05(19.34–50.60) | 21.89(12.90-36.94) | 33.66(15.61–49.37) | 1.15(0.61–2.31) | 12.81(8.27–21.55) | 1.05(0.27–1.93) | 1.53(0.82–3.49) | 64.10(53.85–74.83) | 2.50(1.20–5.90) | 5.75(2.34–10.20) |
Control group | 1.91 × 109(1.42–2.39 × 109) | 33.91(24.25–45.99) | 16.92(9.88–33.70) | 30.35(21.17–44.46) | 1.51(0.40–4.10) | 12.04(7.78–16.26) | 0.67(0.20–12.20) | 1.74(0.74–4.21) | 60.26(44.14–70.18) | 2.33(0.40–2.90) | 5.15(1.78-8.00) |
Z | 1.199 | -0.58 | -3.38 | -1.60 | 0.40 | -1.13 | -0.02 | 0.86 | -5.12 | 0.18 | -0.39 |
P | 0.376 | 0.84 | 0.19 | 0.64 | 0.21 | 0.29 | 1.00 | 0.40 | 0.05 | 0.24 | 0.64 |